Christian Camani

Decarbonizing the industry with Renewable Natural Gas.

Hello and welcome to our LinkedIn company page! At Veesion, we believe that AI should be simple and accessible to everyone. As we collaborate with leaders in the retail industry, we harness the power of artificial intelligence to help retailers effortlessly detect and reduce shoplifting. Our technology is built on the latest advancements in deep learning applied to video, offering solutions that are not only effective but also easy to use. From shoplifting detection to enhancing safety across various industries, our AI is designed to be concrete, simple, and useful. The AI revolution has begun, and its potential is endless. Every professional, in retail, logistics, healthcare, and beyond, should benefit from it. Thats why we focus on creating solutions that are intuitive and accessible to all. Today, we help store owners quickly identify shoplifting incidents. Tomorrow, we aim to expand into any scenario where video AI can make a difference. Operational excellence, continuous improvement, trust, and transparency are at the core of what we do. This is just the beginning. Are you with us? VEESION AI in motion

ONWARD is a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries. ONWARD’s work builds on more than a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories. ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received nine Breakthrough Device Designations from the U.S. FDA encompassing both ARC-IM and ARC-EX. ARC-EX is an external, non-invasive platform consisting of a wearable stimulator and wireless programmer. Positive top-line data were reported in September 2022 from the company’s first pivotal study, called Up-LIFT, evaluating the ability of transcutaneous ARC Therapy to improve upper extremity strength and function. The company is now preparing marketing approval submissions for the U.S. and Europe. ARC-IM consists of an implantable pulse generator and lead placed near the spinal cord. The company completed its first-in-human use of the ARC-IM neurostimulator in May 2022. ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing U.S. presence in Boston, Massachusetts. The company has an academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV).

Frontastic is a computer software company based out of 34 RUE HENRI DUNANT, LAGNY SUR MARNE, France.

Threatray produces code-based threat intelligence by making massive malware repositories and feeds searchable and correlatable. Our deep, data-driven malware search and analytics technology gives threat intel and malware analysts and incident response teams powerful capabilities for rapidly identifying, analyzing and mitigating sophisticated threats using global and organization-specific intelligence.

AVA ANC is a high-performance, wideband, smart Digital Active Noise Cancellation (ANC) Technology, enhanced by unique AI adaptation techniques. It is a patented SW/HW solution (available for licensing) that minimizes unwanted/disruptive audio noise in products & applications such as: 1-Transportation: Automotive, Trains, Airplanes 2-Hearables: TWS Earbuds, headphones, OTC Hearing Enhancement Earbuds, office/call-center headset 3-Voice communication devices: phone, laptop, teleconferencing systems 4-Voice activated smart devices: smartphone, smart TV, smart speaker, connected home, connected car Our ground-breaking Active Noise Cancellation technology is a wide-band solution outperforming all available techniques in the market.

Biograil™ is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming the tremendous market of injectable pharmaceutical products into convenient oral capsules. We strive to make the most effective and convenient pharmaceuticals to patients in innovative and prioprietary ways by combining known technologies.

PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services. As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues. Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing. The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers. PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally. Why not get in touch to see how we can help you with your biosafety testing strategy?

The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and covers hit-generation, hit- to-lead and lead optimization for all targets including orphan GPCRs. InterAx AG has a highly experienced and dedicated team of scientists specialized in AI, mathematical models of signaling pathways, cellular pharmacology and computational chemistry.

Wir bieten Wildbienen-Erlebnisse für Privatpersonen, Bestäubungsservice für Obstbauern und Beratungen für die Gestaltung und Bau von wildbienenfreundlichen Gärten an. Unsere Vision: A buzzing world for all!

With Attolight, Cathodoluminescence (CL) is now available in a streamlined system which integrates CL with both light (LM) and electron microscopy (EM): what was a challenging experiment in the past, often done on klunky, home-made devices can now be done easily and efficiently. Attolight is now changing the landscape: its innovative approach brings nanometer resolution as well as pico-second timing for time-resolved studies, regardless of the wavelengths used. While any material that emits light under electron irradiation can be studied by CL, it is particularly valuable in material studies of semi-conductor materials, phosphor, ceramic, rock and glass. Combining LM, EM with hyperspectral imaging, Attolight’s solution reveals ultra-trace impurities and crystallographic defects not visible using other imaging modalities. Attolight "New Cathodoluminescence"​ solutions support the state-of-the -art research and developments in LEDs, Solar Cells, High Mobility Transitors, new opto-electronical devices, nano-structured semiconductors.

BYHOURS is the first online platform where you can book hotel rooms and decide the check-in time and duration of your micro-stay. BYHOURS offers packs of 3, 6 or 24 hours to suit your schedule, needs, and lifestyle. Now possible to pay only for the time you require. Our philosophy is a fair price, never low cost. We offer the same quality of service as the main hotel chains, allowing you to book by the hour, and adapting to your needs.

CheckYeti was founded in 2014 in Austria and Switzerland by two young entrepreneurs from Salzburg, Stefan Pinggera and Georg Reich. Their vision: To develop an online platform that allows you to search for, compare and book winter and summer activities across Europe. The unique platform has quickly grown to become the European market leader. Today, CheckYeti enables holidaymakers and outdoor enthusiasts from more than 137 countries to book over 12,000 activities across Europe – including skiing & snowboarding, rafting & canyoning, mountain biking, paragliding & ballooning, diving & surfing, jet skiing, boat trips and many more. CheckYeti is active in 16 countries and 1,500+ mountain and beach destinations. The website is available in German, English, French, Italian, Spanish and Dutch. Find the best holiday activity tips on our blog: www.checkyeti.com/blog

We help UX teams find perfect matching test users, anytime, anywhere for any type of user research with total reliability. The core of our solution is an international pool of nearly 1 MILLION test users and a fully automated candidate matching system. We apply state-of-the-art screening and thanks to AI-bases processes, we can ensure pool quality at scale. Describe your target group and follow the recruitment process of your perfect matches in real time! Our hope is that this way, our customers will help us to someday achieve our corporate vision: a world full of happy users.

Decarbonizing the industry with Renewable Natural Gas.

Hello and welcome to our LinkedIn company page! At Veesion, we believe that AI should be simple and accessible to everyone. As we collaborate with leaders in the retail industry, we harness the power of artificial intelligence to help retailers effortlessly detect and reduce shoplifting. Our technology is built on the latest advancements in deep learning applied to video, offering solutions that are not only effective but also easy to use. From shoplifting detection to enhancing safety across various industries, our AI is designed to be concrete, simple, and useful. The AI revolution has begun, and its potential is endless. Every professional, in retail, logistics, healthcare, and beyond, should benefit from it. Thats why we focus on creating solutions that are intuitive and accessible to all. Today, we help store owners quickly identify shoplifting incidents. Tomorrow, we aim to expand into any scenario where video AI can make a difference. Operational excellence, continuous improvement, trust, and transparency are at the core of what we do. This is just the beginning. Are you with us? VEESION AI in motion

ONWARD is a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries. ONWARD’s work builds on more than a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories. ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received nine Breakthrough Device Designations from the U.S. FDA encompassing both ARC-IM and ARC-EX. ARC-EX is an external, non-invasive platform consisting of a wearable stimulator and wireless programmer. Positive top-line data were reported in September 2022 from the company’s first pivotal study, called Up-LIFT, evaluating the ability of transcutaneous ARC Therapy to improve upper extremity strength and function. The company is now preparing marketing approval submissions for the U.S. and Europe. ARC-IM consists of an implantable pulse generator and lead placed near the spinal cord. The company completed its first-in-human use of the ARC-IM neurostimulator in May 2022. ONWARD is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing U.S. presence in Boston, Massachusetts. The company has an academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV).

Frontastic is a computer software company based out of 34 RUE HENRI DUNANT, LAGNY SUR MARNE, France.

Threatray produces code-based threat intelligence by making massive malware repositories and feeds searchable and correlatable. Our deep, data-driven malware search and analytics technology gives threat intel and malware analysts and incident response teams powerful capabilities for rapidly identifying, analyzing and mitigating sophisticated threats using global and organization-specific intelligence.